Open-label, Multicenter Trial to Investigate the Pharmacokinetics of Aripiprazole IM Depot Fornulation (OPC-14597 IMD) by Repeated Dosing in Patients with Schizophrenia
Latest Information Update: 24 Sep 2018
At a glance
- Drugs Aripiprazole (Primary)
- Indications Schizophrenia
- Focus Pharmacokinetics
- Sponsors Otsuka Pharmaceutical
- 01 Jun 2016 New trial record